The 20 Best Atherosclerosis Doctors near Milton, MA

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS).Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease.The author of some 400 original peer-reviewed publications, some 450 reviews, chapters, or other publications, Dr. Libby also serves as an Editor of the leading textbook of cardiovascular medicine.  Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventive cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Dr. Libby is perennially named a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, The Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology. Dr. Libby is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Abdominal Aortic Aneurysm (AAA), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Eric Secemsky is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Secemsky has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Pulmonary Embolism, Atherosclerosis, Angioplasty, and Embolectomy.

Ron Blankstein is a Cardiologist in Boston,, Massachusetts. Dr. Blankstein is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Sarcoidosis, Heart Bypass Surgery, and Cardiac Ablation.

Dr. Paul M. Ridker is director of the Center for Cardiovascular Disease Prevention, a translational research unit at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS).Dr. Ridker received his medical degree from HMS. He then completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Ridker is board certified in internal medicine. He provides outpatient services at the Southern Jamaica Plain Health Center, a public-health clinic affiliated with BWH and HMS. His clinical interests include coronary artery disease and the underlying causes and prevention of atherosclerotic disease.Dr. Ridker is the author of over 500 peer-reviewed publications, 150 reviews and book chapters, and five textbooks related to cardiovascular medicine. Dr. Ridker’s primary research focus has involved inflammatory mediators of heart disease and the molecular and genetic epidemiology of hemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease. Between the years 2000 and 2010, he was among the 10 most often cited researchers in cardiovascular medicine worldwide. Dr. Ridker been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr. Ridker is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Unstable Angina, High Cholesterol, Coronary Heart Disease, and Percutaneous Coronary Intervention (PCI).

Michael Jaff is a primary care provider, practicing in Cardiologist in Boston, Massachusetts. Dr. Jaff is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Pulmonary Embolism, Atherosclerosis, Angioplasty, and Stent Placement.

Jon Cronin is an Internal Medicine provider in Milton, Massachusetts. Dr. Cronin is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Sitosterolemia, Atrial Fibrillation, Inappropriate Sinus Tachycardia (IST), and High Cholesterol.

Daniel Kirshenbaum is an Internal Medicine provider in Milton, Massachusetts. Dr. Kirshenbaum is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Sitosterolemia, Fainting, Inappropriate Sinus Tachycardia (IST), and Familial Ventricular Tachycardia.

Wing Fung is an Internal Medicine provider in Milton, Massachusetts. Dr. Fung is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Pediatric Myocarditis, Endocarditis, Hypertensive Heart Disease, and Necrosis.

Dr. Hicham Skali is a staff cardiologist, a member of the Non-invasive Cardiovascular Imaging Program at Brigham and Women’s Hospital (BWH), and at Brigham and Women’s/ Massachusetts General Health Care Center at Foxborough. He is also the associate director of the BWH Cardiac Rehabilitation program. Dr. Skali is an instructor in medicine at Harvard Medical School.Dr. Skali received his medical degree from University Hassan II/Faculté de Medicine de Casablanca in Morocco. He completed an internal medicine residency and a cardiovascular medicine fellowship at St. Elizabeth’s Medical Center in Boston, followed by a cardiac imaging fellowship at BWH. Dr. Skali is certified as a diplomat in Internal Medicine and Cardiovascular Diseases, as well as board certified in nuclear cardiology and echocardiography.Dr. Skali is also director of the Cardiac Imaging Core Laboratory, and a senior member of the Clinical Endpoints Center at BWH. His research focuses on understanding the complex interactions between clinical and imaging biomarkers, as well as cardiovascular mortality and morbidity in high-risk populations with diabetes or kidney diseases. He has authored over 60 peer-reviewed publications. Dr. Lami is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Arrhythmias, Angina, Atherosclerosis, Pacemaker Implantation, and Cardiac Ablation.

Stephen D. Wiviott, MD, FACC is a graduate of University of Pennsylvania and Harvard Medical School (HMS, Honors). He served as a Medicine resident and Chief Medical Resident at Brigham and Women’s Hospital (BWH). Following his medical residency training, he served as a Cardiology fellow at Johns Hopkins Hospital. He is Associate Professor of Medicine at Harvard Medical School, and a Senior Investigator with the TIMI study group. He attends in the Levine Cardiovascular Intensive Care Unit and general Cardiology service at Brigham and Women's Hospital.As an investigator, Dr. Wiviott has played important roles in the planning, implementation, leadership, and interpretation of multicenter, national, and international clinical trials in acute coronary syndromes including the TRITON-TIMI 38 trial, PRINCIPLE-TIMI 44 and of the TIMI 38 Coronary Stent Registry. He has also served in leadership of trials of secondary prevention of cardiovascular disease as global PI of DECLARE – TIMI 58, CAMELLIA – TIMI 61, and DAPA ACT HF – TIMI 68 assessing CV safety and efficacy of metabolic therapies.  He is the Chairman of the TIMI Clinical Events Committee and recognized as an expert in event definitions and adjudications.  Dr. Wiviott is an author of over 200 peer-reviewed publications in major medical and cardiovascular journals including 15 original articles in the New England Journal of Medicine. He was named in 2014 and 2017 by Thomson Reuters and Clarivate Analytics as one of “The World’s Most Influential Scientific Minds” and in 2016-2020 as a “Highly Cited Researcher,” recognitions inclusive of the top 1% of researchers in Clinical Medicine by citation.  Building on his trials experience, Dr. Wiviott serves as Vice President for Clinical Trials Research and Administration for Mass General Brigham and leads the Mass General Brigham Clinical Trials Office.  The CTO provides contracting, budgeting, and clinical trial management services for Mass General Brigham hospital investigators and industry sponsors and is tasked with supporting and growing clinical trials research at Mass General Brigham. Dr. Wiviott is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Dr. Jorge Plutzky is director of Preventive Cardiology at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.Dr. Plutzky received his medical degree from University of North Carolina at Chapel Hill School of Medicine. He completed a residency in internal medicine at BWH and West Roxbury Veterans Administration Medical Center (now VA Boston Healthcare Systems), as well as a fellowship in cardiology at BWH. Dr. Plutzky is board certified in internal medicine and cardiovascular disease.Dr. Plutzky’s clinical interests include cardiovascular disease, preventive education on cardiac disorders, and the impact of diabetes and bariatric conditions on cardiovascular health. The author of more than 50 peer-reviewed publications, his research interests include metabolic pathways, lipid metabolism, arteriosclerosis, thrombosis and vascular biology. Dr. Plutzky is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are High Cholesterol, Heart Attack, Atherosclerosis, Cardiac Ablation, and Pacemaker Implantation.

Christian T. Ruff, MD, MPH is the Director of General Cardiology in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Associate Professor of Medicine at Harvard Medical School. Dr. Ruff graduated from Harvard University, earned his medical degree at Johns Hopkins University School of Medicine, and his masters of public health from the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital.Dr. Ruff is a Senior Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Genetics Core Laboratory and the Co-Chairman of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator initiated studies of biomarkers and genetic variants to large clinical trials. Dr. Ruff has served on international clinical guideline committees and has been invited to give hundreds of lectures nationally and internationally. He has authored many scholarly articles, editorials, reviews, and book chapters that include the New England Journal of Medicine, Lancet, Journal of the American Medical Association, American Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Nature Reviews Cardiology. Dr. Ruff is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atrial Fibrillation, Heart Attack, Heart Failure, Cardiac Ablation, and Angioplasty.

Mark Creager is a Cardiologist in Boston,, Massachusetts. Dr. Creager is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Prinzmetal's Variant Angina, Leg or Foot Amputation, and Pacemaker Implantation.

Robert Giugliano is a Cardiologist in Boston,, Massachusetts. Dr. Giugliano is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Dr. Thomas Edward Noonan is a cardiovascular medicine specialist at Brigham and Women’s Hospital. In addition, he is an instructor in medicine at Harvard Medical School. He is also a clinical assistant professor of medicine at The Warren Alpert Medical School of Brown University.Dr. Noonan received his medical degree from Pennsylvania State Hershey College of Medicine. He completed an internal medicine residency at Beth Israel Deaconess Medical Center and a cardiology fellowship at Boston Medical Center. He is board certified in internal medicine and cardiovascular disease.The author of more than four peer-reviewed publications, Dr. Noonan’s research focuses on cardiomyopathy and coronary stenosis. Dr. Noonan’s clinical interests include adult cardiology, cardiac catheterization, and echocardiography. Rhode Island Monthly has listed him as a Top Doctor/Cardiology. Dr. Noonan is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Dilated Cardiomyopathy (DCM), and Pacemaker Implantation.

Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS). He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease. Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management. Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors. Dr. Morrow is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Cardiogenic Shock, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Benjamin M. Scirica is a cardiovascular medicine specialist and Professor of Medicine at Harvard Medical School (HMS). He is a Senior Investigator at the Thrombolysis and Myocardial Infarction (TIMI) Study Group and leads the Accelerator for Clinical Transformation, a group that has developed a series of remote disease management programs.Dr. Scirica received his medical degree from Harvard Medical School. He completed an internal medicine residency and a cardiovascular disease fellowship at BWH. He also completed a research fellowship in cardiovascular disease with the TIMI Study Group at BWH and received a master’s degree in public health from Harvard School of Public Health. Dr. Scirica is board certified in cardiovascular disease. His is an attending physician in the Levine Cardiac Intensive Care Unit and in the Watkins Cardiovascular Clinic at BWH. His research interests center on identifying and applying novel therapeutic and care delivery strategies across the spectrum of cardiometabolic disease. Dr. Scirica is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Cardiac Arrest, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Eli Gelfand is an Internal Medicine provider in Boston, Massachusetts. Dr. Gelfand is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), and Pacemaker Implantation.